JP2006518604A5 - - Google Patents

Download PDF

Info

Publication number
JP2006518604A5
JP2006518604A5 JP2006503825A JP2006503825A JP2006518604A5 JP 2006518604 A5 JP2006518604 A5 JP 2006518604A5 JP 2006503825 A JP2006503825 A JP 2006503825A JP 2006503825 A JP2006503825 A JP 2006503825A JP 2006518604 A5 JP2006518604 A5 JP 2006518604A5
Authority
JP
Japan
Prior art keywords
prtp801
plasmid
vegf
pharmaceutical composition
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006503825A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006518604A (ja
JP4652325B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/005372 external-priority patent/WO2004076633A2/en
Publication of JP2006518604A publication Critical patent/JP2006518604A/ja
Publication of JP2006518604A5 publication Critical patent/JP2006518604A5/ja
Application granted granted Critical
Publication of JP4652325B2 publication Critical patent/JP4652325B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006503825A 2003-02-21 2004-02-23 虚血性疾患用の低酸素状態誘導可能vegfプラスミド Expired - Fee Related JP4652325B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44896103P 2003-02-21 2003-02-21
PCT/US2004/005372 WO2004076633A2 (en) 2003-02-21 2004-02-23 Hypoxia inducible vegf plasmid for ischemic disease

Publications (3)

Publication Number Publication Date
JP2006518604A JP2006518604A (ja) 2006-08-17
JP2006518604A5 true JP2006518604A5 (cg-RX-API-DMAC7.html) 2007-04-05
JP4652325B2 JP4652325B2 (ja) 2011-03-16

Family

ID=32927484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006503825A Expired - Fee Related JP4652325B2 (ja) 2003-02-21 2004-02-23 虚血性疾患用の低酸素状態誘導可能vegfプラスミド

Country Status (9)

Country Link
US (2) US7638322B2 (cg-RX-API-DMAC7.html)
EP (1) EP1594549B1 (cg-RX-API-DMAC7.html)
JP (1) JP4652325B2 (cg-RX-API-DMAC7.html)
KR (1) KR101077689B1 (cg-RX-API-DMAC7.html)
AT (1) ATE456380T1 (cg-RX-API-DMAC7.html)
CA (1) CA2516727C (cg-RX-API-DMAC7.html)
DE (1) DE602004025328D1 (cg-RX-API-DMAC7.html)
ES (1) ES2339113T3 (cg-RX-API-DMAC7.html)
WO (1) WO2004076633A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ553162A (en) 2004-08-16 2010-03-26 Quark Biotech Inc Double stranded siRNA compounds that inhibit RRTP801
UY30097A1 (es) 2006-01-20 2007-08-31 Atugen Ag Usos terapeuticos de inhibidores de rtp801
WO2008054534A2 (en) 2006-05-11 2008-05-08 Quark Pharmaceuticals, Inc. Screening systems utilizing rtp801
WO2007141796A2 (en) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Therapeutic uses of inhibitors of rtp801l
WO2008106102A2 (en) 2007-02-26 2008-09-04 Quark Pharmaceuticals, Inc. Inhibitors of rtp801 and their use in disease treatment
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104973A1 (en) * 1997-08-21 2003-06-05 Quark Biotech, Inc. Hypoxia-regulated genes
US6548633B1 (en) * 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides

Similar Documents

Publication Publication Date Title
CN102911918B (zh) 一种基因工程细胞及其在nk细胞扩增中的应用
US20200157515A1 (en) Systems and methods for the treatment of hemoglobinopathies
Sun et al. Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy
US20100172882A1 (en) Compositions and methods for targeted inactivation of hiv cell surface receptors
JP2020040969A5 (cg-RX-API-DMAC7.html)
JP2012510521A5 (cg-RX-API-DMAC7.html)
Christensen et al. Reducible poly (amido ethylenediamine) for hypoxia-inducible VEGF delivery
JP2008507536A5 (cg-RX-API-DMAC7.html)
JP2021528096A5 (cg-RX-API-DMAC7.html)
US20180161455A1 (en) Non-integrating viral delivery system and methods of use therof
AU2019355201A1 (en) Methods for the expansion of mesenchymal stromal cells
CN114788876B (zh) 治疗糖尿病的mRNA药物制剂及其制备方法与应用
JP2018517660A5 (cg-RX-API-DMAC7.html)
JP2002500202A5 (cg-RX-API-DMAC7.html)
Song et al. Therapeutic factors and biomaterial-based delivery tools for degenerative intervertebral disc repair
RU2012143607A (ru) Способ пролиферации кардиомиоцитов с применением микро-рнк
JP2005521632A5 (cg-RX-API-DMAC7.html)
JP2011505798A5 (cg-RX-API-DMAC7.html)
CN107303390A (zh) Dpp4抑制剂在制备治疗低氧性肺动脉高压药物中的用途
WO2021121038A1 (zh) 用于治疗耐药菌感染的外泌体制剂
WO2018009506A1 (en) Erythroid-specific promoter and method of use thereof
US20230265426A1 (en) Combinatorial inhibition of mirnas for treatment of heart failure
CN112891365A (zh) 一种可释放microRNA核酸药物的3D仿生细胞植入体的制备及其应用
WO2020041308A1 (en) Compositions and methods for increasing beiging of white adipose tissue
CN102146433A (zh) 用于指导伊立替康类药物个体化治疗的基因组合